Medlive Technology Co (HKSE:02192) Net Cash per Share : HK$6.18 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Medlive Technology Co's Net Cash per Share for the quarter that ended in Dec. 2023 was HK$6.18.

The historical rank and industry rank for Medlive Technology Co's Net Cash per Share or its related term are showing as below:

HKSE:02192' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.33 Med: 1.37 Max: 4.24
Current: 1.35

During the past 6 years, the highest Price-to-Net-Cash Ratio of Medlive Technology Co was 4.24. The lowest was 1.33. And the median was 1.37.

HKSE:02192's Price-to-Net-Cash is ranked better than
91.67% of 12 companies
in the Medical Distribution industry
Industry Median: 6.73 vs HKSE:02192: 1.35

Medlive Technology Co Net Cash per Share Historical Data

The historical data trend for Medlive Technology Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Net Cash per Share Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Cash per Share

Get a 7-Day Free Trial

-0.01

0.12

6.42

6.25

6.18

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Cash per Share	Get a 7-Day Free Trial					6.42	6.41	6.25	6.28	6.18

Competitive Comparison of Medlive Technology Co's Net Cash per Share

For the Medical Distribution subindustry, Medlive Technology Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlive Technology Co's Price-to-Net-Cash Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Price-to-Net-Cash falls into.

Medlive Technology Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Medlive Technology Co's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

	Net Cash per Share (A: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(4813.606	-	271.929	-	52.319)	/	726.963
=	6.18

Medlive Technology Co's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

	Net Cash per Share (Q: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(4813.606	-	271.929	-	52.319)	/	726.963
=	6.18

Medlive Technology Co (HKSE:02192) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Medlive Technology Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co (HKSE:02192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines